Fact Sheet PDF

999 € million in sales

47% export
(95 countries)

1,348 employees

10 production centers

Ercros: centennial-old tradition that looks into the future

Ercros is an industrial group diversified into three business areas: the Chlorine Derivatives Division, a strategic unit whose common nexus is chlorine; the Intermediate Chemicals Division, focused on formaldehyde chemistry; and the Pharmaceuticals Division, dedicated to pharmaceutical active ingredients. It is a leading company in the main markets in which it operates for most of its products.

The principles that guide their activity are the safety of their facilities and the health of their people, respect for the environment, the quality of their products, and dialogue and transparency with society.

It is listed on the continuous market of the Spanish stock exchange.

Sales and adjusted ebitda of each division (€M)

Main raw materials

Main products

Competitive position

	Spain	Europe	World
Chlorine derivatives
TCCA	1^st	1^st	-
Sodium chlorate	1^st	4^th	-
Sodium hypochlorite	1^st	11^th	-
Caustic potash	1^st	7^th	-
PVC	1^st	9^th	-
Caustic soda	1^st	9^th	-
Intermediate chemicals
Glues and resins	2^nd	7^th	-
Formaldehyde	1^st	5^th	-
Paraformaldehyde	1^st	1^st	1^st
Polyols	1^st	2^nd	3^rd
Moulding compounds	1^st	2^nd	3^rd
Pharmaceuticals
Fusidic acid	-	2^nd	2^nd
Fosfomycins	1^st	2^nd	3^rd
Erythromycins	1^st	1^st	-

Currencies and markets (2022)

Ercros currencies and markets

Diversified by currency

Geographically diversified

Divisional markets

Key figures (€M)

Results account	2021	2022
Income	852.1	1,059.7
Sales of goods	772.3	998.5
Services rendered	16.7	26.4
Other income	52.0	34.8
Expenses	-766.4	-937.0
Supplies and utilities ("S&U")	-547.7	-698.6
Staff costs	-83.6	-89.6
Other expenses	-116.4	-148.9
Ebitda	93.4	122.7
Amortizations and impairments of assets	-31.6	-30.5
Financial results	-2.5	-4.2
Profit before tax	59.3	88.0
Income taxes	-9.9	-17.3
Result from continuing operations	49.4	70.6
Result from discontinued operations	-6.1	-7.7
Profit for the year	43.3	63.0
Balance sheet	31-12-2021	31-12-2022
Non-current assets	358.7	393.0
Working capital	58.1	77.4
Equity	331.6	360.7
Net financial debt ("NFD")	65.8	75.1
Provisions and other borrowings	19.4	34.6

Distribution of free cash flow (2022)

Appropriation profit (2022)

The share

Market capitalisation

(08-12-23) (EUR M)

225.4

Volume

(08-12-23) (shares)

59,147

Share capital

(31-12-22) (EUR M)

29.0

Number of shares

(08-12-23) (million shares)

91.4

Ratios

Financial	31-12-2021	31-12-2022
Leverage [NFD ÷ total equity]	0.20	0.21
Solvency [NFD ÷ adjusted ebitda]	0.77	0.53
Liquidity [current assets ÷ current liabilities]	1.30	1.35
ROCE [ebit ÷ resources used] (%)	12.88	19.59
Operating
Productivity [value added ÷ n. of employees] (€/person)	129,906	157,450
Margin of contribution/sales [(sales + provision of services + S&U + stock reduction) + (sales + provision of services)] (%)	33.40	32.42
Margin of adjusted ebitda/sales (%)	10.76	13.94
Stock
EPS [profit ÷ n. of shares] (€)	0.429	0.640
PER [capitalization ÷ profit]	6.93	4.97

ESG Indicators

	2021	2022
Women (% headcount)	17.2	17.7
Capex (€M)	34.6	49.5
Sustainability expenditure (€M)	24.7	28.0
Expenses and investment in R+D (€M)	6.6	6.7
Training (annual hours/person)	21.3	24.7
Accident frequency rate	1.8	3.1
CO₂ emissions index (% change vs previous year)	-13.5	-5.3
Energy consumption (% change vs previous year)	-7.8	2.4

Contact us

Contact: ercros@ercros.es

Web: www.ercros.es

Supplied by ©